Check all documented drug-to-drug interactions. Major, moderate, and minor interactions with descriptions.
A therapy excluded from this list does not necessarily mean no interaction exists between that therapy and Mycamine. Always confirm against the full prescribing information.
100 interactions
Abacavir
Abacavir may increase the hepatotoxic activities of Micafungin.
Level 2 evidence
Abiraterone
Micafungin may increase the hepatotoxic activities of Abiraterone.
Level 2 evidence
Acarbose
Acarbose may increase the hepatotoxic activities of Micafungin.
Level 2 evidence
Acenocoumarol
The therapeutic efficacy of Acenocoumarol can be increased when used in combination with Micafungin.
Level 1 evidence
Acetaminophen
Acetaminophen may increase the hepatotoxic activities of Micafungin.
Level 2 evidence
Acetazolamide
Acetazolamide may increase the hepatotoxic activities of Micafungin.
Level 2 evidence
Acitretin
Acitretin may increase the hepatotoxic activities of Micafungin.
Level 2 evidence
Albendazole
Albendazole may increase the hepatotoxic activities of Micafungin.
Level 2 evidence
Allopurinol
Allopurinol may increase the hepatotoxic activities of Micafungin.
Level 2 evidence
Aminosalicylic acid
Aminosalicylic acid may increase the hepatotoxic activities of Micafungin.
Level 2 evidence
Amiodarone
Amiodarone may increase the hepatotoxic activities of Micafungin.
Level 2 evidence
Anidulafungin
Anidulafungin may increase the hepatotoxic activities of Micafungin.
Mycamine (Micafungin Sodium) has 492 documented drug interactions. Always review the full list with a pharmacist before co-prescribing.
Mycamine (Micafungin Sodium) has 1 major, 151 moderate, and 340 minor documented interactions.
A therapy excluded from this list does not necessarily mean no interaction exists between that therapy and Mycamine. Always confirm against the full prescribing information.